🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II study to determine the safety and efficacy of tislelizum...
Status
Unknown
Location
Tianjin Medical University Second Hospital
Start Date
2021-12-27
Trial ID
NCT05418309
Treatments Being Tested
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
This is an open, multi-cohort, multi-center, exploratory and phase II clini...
Status
Unknown
Location
Jiangsu Cancer Hospital
Start Date
2021-12-01
Trial ID
NCT05262335
A study to measure the safety and effectiveness of S-3304 when given in com...
Status
Completed
Location
Scripps Cancer Institute
Start Date
2003-02
Trial ID
NCT00078390
Treatments Being Tested
This phase II trial studies how well onvansertib in combination with gemcit...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2024-08-01
Trial ID
NCT06398587
Research purpose: Degree of continuous intravenous pumping Endostar (human...
Status
Unknown
Location
Jiangsu Taizhou People's Hospital
Start Date
2015-02
Trial ID
NCT02513355
Treatments Being Tested
This is a Single arm, Simon's two stage pilot study in which patients with ...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2024-12-16
Trial ID
NCT06576635
Treatments Being Tested
This phase II trial on the assumption that abraxane and cisplatin combinati...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2010-06
Trial ID
NCT01149798
Treatments Being Tested
This is an investigator-initiated industry-supported phase 1 clinical trial...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-12
Trial ID
NCT05075993
Lung cancer is the second most common malignancy and mortality rate in the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-09
Trial ID
NCT06048315
Treatments Being Tested